ZA200400269B - Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone - Google Patents

Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone

Info

Publication number
ZA200400269B
ZA200400269B ZA2004/00269A ZA200400269A ZA200400269B ZA 200400269 B ZA200400269 B ZA 200400269B ZA 2004/00269 A ZA2004/00269 A ZA 2004/00269A ZA 200400269 A ZA200400269 A ZA 200400269A ZA 200400269 B ZA200400269 B ZA 200400269B
Authority
ZA
South Africa
Prior art keywords
quinolone
fluoro
ion exchange
pharmaceutical preparations
exchange resins
Prior art date
Application number
ZA2004/00269A
Other languages
English (en)
Inventor
Mertin Dirk
Block Wolfgang
Jurgen Hamann Hans
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ZA200400269B publication Critical patent/ZA200400269B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA2004/00269A 2001-07-17 2004-01-14 Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone ZA200400269B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10134719A DE10134719A1 (de) 2001-07-17 2001-07-17 Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
PCT/EP2002/007417 WO2003007995A2 (de) 2001-07-17 2002-07-04 Pharmazeutische zubereitungen enthaltend fluorochinolonbeladene ionentauscherharze

Publications (1)

Publication Number Publication Date
ZA200400269B true ZA200400269B (en) 2005-03-30

Family

ID=7692081

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2004/00269A ZA200400269B (en) 2001-07-17 2004-01-14 Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone

Country Status (13)

Country Link
US (1) US20040247560A1 (https=)
EP (1) EP1411894A2 (https=)
JP (1) JP2005500332A (https=)
AR (1) AR034777A1 (https=)
AU (1) AU2002345086B2 (https=)
BR (1) BR0211149A (https=)
CA (1) CA2453616A1 (https=)
DE (1) DE10134719A1 (https=)
MX (1) MXPA04000332A (https=)
NO (1) NO20040205L (https=)
NZ (1) NZ530604A (https=)
WO (1) WO2003007995A2 (https=)
ZA (1) ZA200400269B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
EP2343089A4 (en) 2008-09-23 2013-05-01 Jaer S A Lab USE OF XYLITOL OR DERIVATIVES THEREOF FOR MASKING THE TASTE OF CHEMOTHERAPEUTIC MEDICAMENTS OF THE CHINOLO-N-NAPHTHYRIDONE-CARBOXYLIC ACID GROUP FOR PIG DICULTINATION
DE102012021559A1 (de) 2012-11-02 2014-05-08 Technische Universität Bergakademie Freiberg Verfahren zur Herstellung von submikronen makroporösen Ionenaustauschermaterialien durch mechansiche Zerkleinerung
US9669010B2 (en) 2012-12-06 2017-06-06 Bio Health Solutions, Llc Treatment for chronic kidney disease
DK2928461T3 (da) * 2012-12-06 2019-11-25 Bio Health Solutions Llc Behandling til kronisk nyresygdom
EP2808319A1 (en) * 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
CA3098060A1 (en) 2018-04-25 2019-10-31 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung

Also Published As

Publication number Publication date
BR0211149A (pt) 2004-06-29
NZ530604A (en) 2006-09-29
CA2453616A1 (en) 2003-01-30
EP1411894A2 (de) 2004-04-28
AU2002345086B2 (en) 2007-05-24
US20040247560A1 (en) 2004-12-09
DE10134719A1 (de) 2003-02-06
WO2003007995A2 (de) 2003-01-30
WO2003007995A3 (de) 2003-07-31
JP2005500332A (ja) 2005-01-06
MXPA04000332A (es) 2005-04-19
NO20040205L (no) 2004-01-16
AR034777A1 (es) 2004-03-17

Similar Documents

Publication Publication Date Title
AU2002361453A1 (en) Metered dose inhaler
IL148406A0 (en) Pharmaceutical tramadol salts
AU2002356653A1 (en) Radiotherapy system
AUPR711701A0 (en) Magnetic field therapy
SG86444A1 (en) Decaborane ion source
AU2001237827A1 (en) Radioactive therapeutic liposomes
IL142515A0 (en) Pharmaceutical kit
AU5313800A (en) Multicomponent ion exchange resins
AU5279800A (en) Ion exchange resins and methods of making the same
AU2002366160A8 (en) Zinc-alkaline battery containing lambda-mn02
AU2002341717A8 (en) Cell therapy system
AU142851S (en) Pharmaceutical kit
AU4430301A (en) Ion exchange materials
GB2362080B (en) Multi-leaf collimator
AU2002346807A1 (en) Genes coding for metabolic pathway proteins
IL144120A0 (en) Defibrillator system
ZA200400269B (en) Pharmaceutical preparations containing ion exchange resins charged with fluoro-quinolone
AU1956401A (en) Antimicrobial synthetic ion exchange resins
AU2002345086A1 (en) Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone
AU6203001A (en) Capsule for magnetic field therapy
GB0026425D0 (en) Prescription administration system
AU2002356058A1 (en) Billing system
AU2002220891A1 (en) Collimator lenses
AU3922601A (en) A radiopharmaceutical for radionuclide tumor therapy
AU2002246321A1 (en) Ion exchanger